As reported, ubiquitin-conjugating enzyme E2C (UBE2C), belonging to the E2 ubiquitin-conjugating enzyme family, plays crucial roles in a variety of malignancies, namely breast cancer [58], colorectal cancer [59], melanoma [60], and hepatocellular carcinoma [61]. Here, UBE2C is linked to breast carcinoma.